Long-term impact of endometrial cancer diagnosis and treatment on health-related quality of life and cancer survivorship

Citation for published version (APA): de Boer, S. M., Nout, R. A., Jurgenliemk-Schulz, I. M., Jobsen, J. J., Lutgens, L. C. H. W., van der SteenBanasik, E. M., ... Creutzberg, C. L. (2015). Long-term impact of endometrial cancer diagnosis and treatment on health-related quality of life and cancer survivorship: Results from the randomized PORTEC-2 trial. International Journal of Radiation Oncology Biology Physics, 93(4), 797-809. https://doi.org/10.1016/j.ijrobp.2015.08.023

[1]  D. Gaffney,et al.  Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers. , 2015, Gynecologic oncology.

[2]  Gaetano Rocco,et al.  Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Danièle Williaume,et al.  Impact of post operative intensity modulated radiotherapy on acute gastro-intestinal toxicity for patients with endometrial cancer: results of the phase II RTCMIENDOMETRE French multicentre trial. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  K. Pennert,et al.  Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial , 2013, The Lancet.

[5]  C. Muller,et al.  A pilot randomized control trial to evaluate pelvic floor muscle training for urinary incontinence among gynecologic cancer survivors. , 2012, Gynecologic oncology.

[6]  S. Zimmerman,et al.  Assessing the impact of cancer among Dutch non‐Hodgkin lymphoma survivors compared with their American counterparts: a cross‐national study , 2013, Psycho-oncology.

[7]  P. Ganz,et al.  A procedure for obtaining Impact of Cancer version 2 scores using version 1 responses , 2013, Quality of Life Research.

[8]  H. Putter,et al.  Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data. , 2012, European journal of cancer.

[9]  P. Fayers,et al.  Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. , 2012, European journal of cancer.

[10]  Jae‐Young Lim,et al.  Effect of a pelvic floor muscle training program on gynecologic cancer survivors with pelvic floor dysfunction: a randomized controlled trial. , 2012, Gynecologic oncology.

[11]  P. Fayers,et al.  Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  R. Angioli,et al.  Long-term cervical cancer survivors suffer from pelvic floor symptoms. , 2010, Gynecologic oncology.

[13]  H. Putter,et al.  Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial , 2010, The Lancet.

[14]  Gunnar Steineck,et al.  Self-reported symptoms of faecal incontinence among long-term gynaecological cancer survivors and population-based controls. , 2010, European journal of cancer.

[15]  Hein Putter,et al.  Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  T. Whelan,et al.  Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis , 2009, The Lancet.

[17]  P. Ganz,et al.  Refinement and psychometric evaluation of the impact of cancer scale. , 2008, Journal of the National Cancer Institute.

[18]  S. Fosså,et al.  An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. , 2008, European journal of cancer.

[19]  H. Geinitz,et al.  Late rectal symptoms and quality of life after conformal radiation therapy for prostate cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  P. Ganz,et al.  Assessing the impact of cancer: development of a new instrument for long‐term survivors , 2006, Psycho-oncology.

[21]  M. Maiman,et al.  A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. , 2004, Gynecologic oncology.

[22]  A. Bottomley,et al.  An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. , 2003, European journal of cancer.

[23]  P. Koper,et al.  The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial , 2002 .

[24]  P. Koper,et al.  Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. , 2000 .

[25]  D. Osoba,et al.  Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  P. Carroll,et al.  The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. , 1995, International journal of radiation oncology, biology, physics.

[27]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[28]  R. M. Hicks,et al.  The subcellular basis of damage to the human urinary bladder induced by irradiation , 1984, The Journal of pathology.

[29]  V. Abeler,et al.  Postoperative External Irradiation and Prognostic Parameters in Stage I Endometrial Carcinoma: CLINICAL AND HISTOPATHOLOGIC STUDY OF 540 PATIENTS , 1980, Obstetrics and gynecology.